Publication

Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure

Vegter, E. L., Ovchinnikova, E. S., Sillje, H. H. W., Meems, L. M. G., van der Pol, A., van der Velde, A. R., Berezikov, E., Voors, A. A., de Boer, R. A. & van der Meer, P., 5-May-2017, In : PLoS ONE. 12, 5, 14 p., e0177242.

Research output: Contribution to journalArticleAcademicpeer-review

Introduction

We recently identified a set of plasma microRNAs (miRNAs) that are downregulated in patients with heart failure in comparison with control subjects. To better understand their meaning and function, we sought to validate these circulating miRNAs in 3 different well-established rat and mouse heart failure models, and correlated the miRNAs to parameters of cardiac function.

Methods

The previously identified let-7i-5p, miR-16-5p, miR-18a-5p, miR-26b-5p, miR-27a-3p, miR30e-5p, miR-199a-3p, miR-223-3p, miR-423-3p, miR-423-5p and miR-652-3p were measured by means of quantitative real time polymerase chain reaction (qRT-PCR) in plasma samples of 8 homozygous TGR(mREN2)27 (Ren2) transgenic rats and 8 (control) Sprague-Dawley rats, 6 mice with angiotensin II-induced heart failure (AngII) and 6 control mice, and 8 mice with ischemic heart failure and 6 controls. Circulating miRNA levels were compared between the heart failure animals and healthy controls.

Results

Ren2 rats, AngII mice and mice with ischemic heart failure showed clear signs of heart failure, exemplified by increased left ventricular and lung weights, elevated end-diastolic left ventricular pressures, increased expression of cardiac stress markers and reduced left ventricular ejection fraction. All miRNAs were detectable in plasma from rats and mice. No significant differences were observed between the circulating miRNAs in heart failure animals when compared to the healthy controls (all P>0.05) and no robust associations with cardiac function could be found.

Conclusions

The previous observation that miRNAs circulate in lower levels in human patients with heart failure could not be validated in well-established rat and mouse heart failure models. These results question the translation of data on human circulating miRNA levels to experimental models, and vice versa the validity of experimental miRNA data for human heart failure.

Original languageEnglish
Article numbere0177242
Number of pages14
JournalPLoS ONE
Volume12
Issue number5
Publication statusPublished - 5-May-2017

    Keywords

  • CARDIAC-HYPERTROPHY, BIOMARKERS, HYPERTENSION, PROGRESSION, DISEASE, INJURY, KINASE

Download statistics

No data available

ID: 46955353